Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Asset Utilization Ratio (2016 - 2025)

IGC Pharma has reported Asset Utilization Ratio over the past 15 years, most recently at 0.13 for Q3 2025.

  • Quarterly Asset Utilization Ratio rose 10.81% to 0.13 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.13 through Sep 2025, up 10.81% year-over-year, with the annual reading at 0.14 for FY2025, 37.22% up from the prior year.
  • Asset Utilization Ratio was 0.13 for Q3 2025 at IGC Pharma, down from 0.16 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.16 in Q2 2025 and troughed at 0.01 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.08 (2023), against an average of 0.07.
  • Year-over-year, Asset Utilization Ratio crashed 89.41% in 2021 and then soared 277.81% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then soared by 277.81% to 0.04 in 2022, then skyrocketed by 112.06% to 0.09 in 2023, then skyrocketed by 45.12% to 0.13 in 2024, then decreased by 1.61% to 0.13 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Asset Utilization Ratio are 0.13 (Q3 2025), 0.16 (Q2 2025), and 0.14 (Q1 2025).